Arovella Therapeutics (ALA.AU) Q1 2026 Earnings

19FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.01
-0
-0
-0

Details

Expected EPS
-0.0037803982899999996
Actual EPS
-0.001512159316
Surprise EPS
0
Surprise Percent
+60%

Description

Arovella Therapeutics (ALA.AU) has reported earnings of -0.001512159316 per share for Q1 2026.

0 Comments

Share your thoughts